Diagnostic Medical Systems SA - Asset Resilience Ratio
Diagnostic Medical Systems SA (ALDMS) has an Asset Resilience Ratio of 1.39% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Diagnostic Medical Systems SA (ALDMS) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Diagnostic Medical Systems SA's Asset Resilience Ratio has changed over time. See Diagnostic Medical Systems SA book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Diagnostic Medical Systems SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Diagnostic Medical Systems SA market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €795.00K | 1.39% |
| Total Liquid Assets | €795.00K | 1.39% |
Asset Resilience Insights
- Limited Liquidity: Diagnostic Medical Systems SA maintains only 1.39% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Diagnostic Medical Systems SA Industry Peers by Asset Resilience Ratio
Compare Diagnostic Medical Systems SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Diagnostic Medical Systems SA (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Diagnostic Medical Systems SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.32% | €711.00K ≈ $831.23K |
€53.95 Million ≈ $63.07 Million |
-0.56pp |
| 2023-12-31 | 1.88% | €959.00K ≈ $1.12 Million |
€51.14 Million ≈ $59.79 Million |
+1.12pp |
| 2022-12-31 | 0.76% | €409.00K ≈ $478.16K |
€53.89 Million ≈ $63.01 Million |
+0.76pp |
| 2021-12-31 | 0.00% | €-1.00K ≈ $-1.17K |
€53.03 Million ≈ $62.00 Million |
0.00pp |
| 2020-12-31 | 0.00% | €1.00K ≈ $1.17K |
€45.80 Million ≈ $53.54 Million |
-7.65pp |
| 2018-12-31 | 7.66% | €2.82 Million ≈ $3.30 Million |
€36.84 Million ≈ $43.07 Million |
-8.09pp |
| 2017-12-31 | 15.74% | €6.31 Million ≈ $7.38 Million |
€40.08 Million ≈ $46.86 Million |
-5.64pp |
| 2016-12-31 | 21.38% | €10.69 Million ≈ $12.49 Million |
€49.98 Million ≈ $58.43 Million |
+17.01pp |
| 2015-12-31 | 4.37% | €2.03 Million ≈ $2.37 Million |
€46.42 Million ≈ $54.27 Million |
-8.32pp |
| 2014-12-31 | 12.69% | €5.00 Million ≈ $5.85 Million |
€39.40 Million ≈ $46.06 Million |
+12.44pp |
| 2013-12-31 | 0.25% | €59.00K ≈ $68.98K |
€23.57 Million ≈ $27.55 Million |
-6.45pp |
| 2012-12-31 | 6.70% | €1.55 Million ≈ $1.81 Million |
€23.16 Million ≈ $27.07 Million |
-- |
About Diagnostic Medical Systems SA
Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.